Earnings History Data for Omega Therapeutics, Inc. (OMGA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Omega Therapeutics, Inc.

Omega Therapeutics Inc. is a development-stage biotechnology company. Its OMEGA Epigenomic Programming(TM) platform harness the power of epigenetics to develop a new class of DNA-sequence-targeting, mRNA-encoded programmable epigenetic medicines. Omega Therapeutics Inc. is based in CAMBRIDGE, Mass.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-11-2024	PM		OMGA	Omega Therapeutics, Inc.	62.88	-0.30	-0.29	-0.40	Omega Therapeutics reports Q3 results [11/15/2024 9:31 AM]	0.8398	-0.17 (-16.85%)	1.01	0.0 (0.00%)	0.77 - 6.30	1,322,718	240,000	11,011
Omega Therapeutics reports Q3 results [11/15/2024 9:31 AM] Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio [Nov-13-24 08:00AM] Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner [Nov-13-24 08:00AM] Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue Estimates [Nov-14-24 05:40PM] Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results [Nov-14-24 04:05PM]
06-08-2024	PM		OMGA	Omega Therapeutics	90.00	-0.30	-0.36	0.00	Omega Therapeutics GAAP EPS of -$0.30, revenue of $2.13M [8/6/2024 8:54 AM]	1.65	0.10 (6.82%)	1.51	-0.03 (-1.95%)	1.30 - 6.30	410,586	300,000	224
Omega Therapeutics GAAP EPS of -$0.30, revenue of $2.13M [8/6/2024 8:54 AM]
06-05-2024	PM		OMGA	Omega Therapeutics	152.00	-0.36	-0.38	0.00	Omega Therapeutics GAAP EPS of -$0.36, revenue of $2.36M [5/6/2024 7:54 AM]	2.27	-0.31 (-11.82%)	2.51	-0.07 (-2.71%)	1.30 - 10.09	534,784	310,000	1,439
Omega Therapeutics GAAP EPS of -$0.36, revenue of $2.36M [5/6/2024 7:54 AM]
09-11-2023	PM		OMGA	Omega Therapeutics	100.00	-0.40	-0.56	0.00	Omega Therapeutics GAAP EPS of -$0.40 beats by $0.15, revenue of $0.8M beats by $0.42M [11/9/2023 1:32 PM]	1.72	-0.06 (-3.37%)	1.83	0.05 (2.81%)	1.30 - 11.98	139,279	360,000	1,873
Omega Therapeutics GAAP EPS of -$0.40 beats by $0.15, revenue of $0.8M beats by $0.42M [11/9/2023 1:32 PM]
04-05-2023	PM		OMGA	Omega Therapeutics, Inc.	446.24	-0.50	-0.64	-0.42	Omega Therapeutics GAAP EPS of -$0.50 beats by $0.13, revenue of $0.52M beats by $0.21M [5/4/2023 10:42 AM]	8.78	0.72 (8.93%)	8.06	0.0 (0.00%)	1.98 - 11.98	42,635	70,000	201
Omega Therapeutics GAAP EPS of -$0.50 beats by $0.13, revenue of $0.52M beats by $0.21M [5/4/2023 10:42 AM]
01-03-2023	PM		OMGA	Omega Therapeutics	280.00	-0.64	-0.62	0.00	Omega Therapeutics GAAP EPS of -$0.64 misses by $0.02, revenue of $0.73M beats by $0.47M [3/1/2023 8:57 AM]	6.26	-0.20 (-3.02%)	0.0	0.0 (0.00%)	1.98 - 12.03	36,048	40,000	0
Omega Therapeutics rises ~11% as chairman buys stock worth $19.2M [2/28/2023 3:39 AM] Omega Therapeutics GAAP EPS of -$0.64 misses by $0.02, revenue of $0.73M beats by $0.47M [3/1/2023 8:57 AM]
08-11-2022	PM		OMGA	Omega Therapeutics	229.00	-0.54	-0.63	0.00	Omega Therapeutics GAAP EPS of -$0.54 beats by $0.07, revenue of $0.6M beats by $0.5M [11/8/2022 9:09 AM]	4.69	-0.08 (-1.68%)	4.77	0.0 (0.00%)	1.98 - 22.87	33,838	30,000	297
Omega Therapeutics GAAP EPS of -$0.54 beats by $0.07, revenue of $0.6M beats by $0.5M [11/8/2022 9:09 AM] Omega Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights [Nov-08-22 07:00AM]
04-05-2022	AH		OMGA	Omega Therapeutics	163.00	-0.42	-0.57	0.00	Omega Therapeutics GAAP EPS of -$0.42 beats by $0.15, revenue of $0.27M [5/4/2022 5:45 PM]	3.24	-0.07 (-2.11%)	3.39	0.08 (2.42%)	2.96 - 31.41	279,047	160,229	120
Omega Therapeutics GAAP EPS of -$0.42 beats by $0.15, revenue of $0.27M [5/4/2022 5:45 PM] Omega Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress [May-04-22 04:01PM] Omega Therapeutics to Unveil Preclinical Data on Epigenomic Programming of MYC with Epigenomic Controllers as a Promising Therapeutic Approach in Non-Small Cell Lung Cancer at the 25th Annual ASGCT Meeting [May-03-22 07:00AM]
10-03-2022	PM	7:00 AM ET (Mar 10)	OMGA	Omega Therapeutics, Inc.	447.17	-0.44	-0.57	0.00	Omega Therapeutics GAAP EPS of -$0.44 beats by $0.19, revenue of $0.14M [3/10/2022 8:30 AM]	11.49	0.40 (3.61%)	10.34	0.0 (0.00%)	8.52 - 31.41	33,620	95,420	516
Omega Therapeutics GAAP EPS of -$0.44 beats by $0.19, revenue of $0.14M [3/10/2022 8:30 AM] Omega Therapeutics to Present Preclinical Data for OTX-2002 at the American Association for Cancer Research Annual Meeting 2022 [Mar-08-22 05:05PM] Omega Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Outlines Key Corporate Objectives for 2022 [Mar-10-22 07:00AM]
10-11-2021	PM		OMGA	Omega Therapeutics	984.00	-0.57	-0.49	0.00	Omega Therapeutics EPS misses by $0.06 [11/10/2021 9:24 AM]	22.05	1.44 (6.99%)	0.0	0.0 (0.00%)	15.50 - 31.41	51,935	100,000	0
Omega Therapeutics EPS misses by $0.06 [11/10/2021 9:24 AM] Omega Therapeutics Reports Third Quarter 2021 Financial Results and Outlines Key Corporate Objectives [Nov-10-21 07:00AM] Omega Therapeutics to Present at the Jefferies London Healthcare Conference [Nov-09-21 07:00AM]